Skip to main content
Clinical Trials/NCT03638973
NCT03638973
Unknown
Not Applicable

Randomized Prospective Study for the Comparison of Sample Biopsy Using Scalpel or Er:YAG Laser

University of Zurich1 site in 1 country44 target enrollmentNovember 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Laser Burn
Sponsor
University of Zurich
Enrollment
44
Locations
1
Primary Endpoint
histological assessability
Last Updated
7 years ago

Overview

Brief Summary

For certain changes in the oral mucosa a histopathological examination of the affected tissue is indicated to confirm the diagnosis. The gold standard is the biopsy by scalpel. The aim of this study is to compare the alternative method of tissue sampling using the erbium doped yttrium aluminium garnet (Er:YAG) laser with the gold Standard.

Detailed Description

Various parameters are compared, such as the pain intensity during and after the biopsy, the evaluation of the tissue removed by the histopathologist, the occurrence of bleeding during and after the removal and the time required for both therapies. Patients who agree to participate in the study will be randomized (randomly) to either therapy.

Registry
clinicaltrials.gov
Start Date
November 1, 2018
End Date
November 1, 2020
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Indication for biopsy of the oral mucosa
  • male and female adult patients
  • Written consent of the participating persons after clarification

Exclusion Criteria

  • pregnancy
  • Taking blood thinners
  • Known infectious diseases
  • Untreated diabetes mellitus
  • Taking immunosuppressants

Outcomes

Primary Outcomes

histological assessability

Time Frame: 13 month

The primary endpoint is the histological assessability of the samples. This is evaluated by the histologist and divided into degrees 0-3. The Subdivision of the artifacts takes place according to the following degrees: 0: none, 1: slight artifacts, not affecting the evaluation of the sample, 2: moderate artifacts, slight deterioration in the evaluability of the sample, 3: severe artifacts, severely impaired

Secondary Outcomes

  • postoperative pain(13 month)
  • postoperative bleeding(13 month)
  • time for removal(13 month)

Study Sites (1)

Loading locations...

Similar Trials